Ruth Berry is the Director of Analytical Strategy at GentiBio. Prior to joining GentiBio, Ruth was the Associate Director of Analytical Strategy at Juno Therapeutics, building a team that supported early and mid-phase cell therapy products. Ruth held multiple roles at Juno Therapeutics, include CMC Lead and Analytical Lead for multiple early stage cell therapy programs, Molecular Assay team lead, and method developer. Prior to joining the cell therapy community, Ruth taught Biology and Microbiology at Umpqua Community College. Ruth holds a BA in Biology from Grinnell College and a PhD in Cellular and Molecular Biology from Northwestern University.
Ruth Berry, PhD
Director, Analytical Development Strategy
